UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

The Low Density Lipoprotein Receptor Regulates the Level of Central Nervous System Human and Murine Apolipoprotein E but Does Not Modify Amyloid Plaque Pathology in PDAPP Mice

The Journal of biological chemistry, 2005-07, Vol.280 (27), p.25754-25759

2005

Volltextzugriff (PDF)

Nuclear Targeting by the Growth Factor Midkine

Molecular and Cellular Biology, 2002-10, Vol.22 (19), p.6788-6796

2002

Volltextzugriff (PDF)

Sorting nexin 17 facilitates LRP recycling in the early endosome

The EMBO journal, 2005-08, Vol.24 (16), p.2851-2861

2005

Volltextzugriff (PDF)

Premature Ligand-Receptor Interaction during Biosynthesis Limits the Production of Growth Factor Midkine and Its Receptor LDL Receptor-related Protein 1

The Journal of biological chemistry, 2011-03, Vol.286 (10), p.8405-8413

2011

Volltextzugriff (PDF)

Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding

Journal of cell science, 2005-11, Vol.118 (22), p.5305-5314

2005

Volltextzugriff (PDF)

Housing for People with Disabilities: A Review of State Olmstead and HUD Consolidated Plans

Journal of planning education and research, 2023-03, Vol.43 (1), p.20-34

2023

Volltextzugriff (PDF)

Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration

The Journal of biological chemistry, 2002-11, Vol.277 (44), p.42366-42371

2002

Volltextzugriff (PDF)

The need for improvement in the management of fatigue, depression and pain in pancreatic cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.429-429

2019

Volltextzugriff (PDF)

Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1566-1566

2020

Volltextzugriff (PDF)

Urban climate change plans: how holistic?

Local environment, 2011-04, Vol.16 (4), p.397-416

2011

Volltextzugriff (PDF)

The economic and workforce development activities of American business associations

Economic development quarterly, 2008-08, Vol.22 (3), p.213-227

2008

Volltextzugriff (PDF)

Independent and Cooperative Roles of N-Glycans and Molecular Chaperones in the Folding and Disulfide Bond Formation of the Low-Density Lipoprotein (LDL) Receptor-Related Protein

Biochemistry (Easton), 2005-04, Vol.44 (15), p.5794-5803

2005

Volltextzugriff (PDF)

Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4149-4149

2023

Volltextzugriff (PDF)

Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase

The Journal of biological chemistry, 2004-08, Vol.279 (33), p.35037-35046

2004

Volltextzugriff (PDF)

The Putative Tumor Suppressor LRP1B, a Novel Member of the Low Density Lipoprotein (LDL) Receptor Family, Exhibits Both Overlapping and Distinct Properties with the LDL Receptor-related Protein

The Journal of biological chemistry, 2001-08, Vol.276 (31), p.28889-28896

2001

Volltextzugriff (PDF)

The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7017-7017

2020

Volltextzugriff (PDF)

Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway

Molecular biology of the cell, 2002-09, Vol.13 (9), p.3325-3335

2002

Volltextzugriff (PDF)

Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4124-4124

2022

Volltextzugriff (PDF)

Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS4188-TPS4188

2022

Volltextzugriff (PDF)

Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.154-154

2020

Volltextzugriff (PDF)

Association of pancreatic adenocarcinoma location (head/body/tail) with DDR mutation status and response to platinum-based therapy

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.612-612

2022

Volltextzugriff (PDF)

Real-world clinical outcomes and molecular features of lung-specific and liver-specific metastases in pancreatic ductal adenocarcinoma (PDAC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.532-532

2022

Volltextzugriff (PDF)

Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4641-4641

2020

Volltextzugriff (PDF)

Real-world outcomes in pancreatic adenocarcinoma (PDAC) and persona types with implications for standard of care (SOC) therapy (Tx)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.735-735

2020

Volltextzugriff (PDF)

Improved overall survival (OS) for advanced pancreatic cancer (PDAC) patients (pts) enrolled in the Know Your Tumor (KYT) program whose tumors harbored highly actionable molecular alterations and who received molecularly-matched therapies (tx)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4138-4138

2019

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(117)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(144)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(55)
Humans
(47)
Animals
(19)
Male
(19)
Female
(17)
Biological And Medical Sciences
(14)
Mice
(11)
Biochemistry & Molecular Biology
(10)
Fundamental And Applied Biological Sciences. Psychology
(8)
Public Health
(8)
Adult
(7)
Child
(7)
Medical Sciences
(7)
Physical Sciences
(7)
Social Sciences
(7)
Aged
(6)
Cell Biology
(6)
Cho Cells
(6)
Cricetinae
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Low Density Lipoprotein Receptor Regulates the Level of Central Nervous System Human and Murine Apolipoprotein E but Does Not Modify Amyloid Plaque Pathology in PDAPP Mice

Nuclear Targeting by the Growth Factor Midkine

Sorting nexin 17 facilitates LRP recycling in the early endosome

Premature Ligand-Receptor Interaction during Biosynthesis Limits the Production of Growth Factor Midkine and Its Receptor LDL Receptor-related Protein 1

Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding

Housing for People with Disabilities: A Review of State Olmstead and HUD Consolidated Plans

Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration

The need for improvement in the management of fatigue, depression and pain in pancreatic cancer

Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic

Urban climate change plans: how holistic?

The economic and workforce development activities of American business associations

Independent and Cooperative Roles of N-Glycans and Molecular Chaperones in the Folding and Disulfide Bond Formation of the Low-Density Lipoprotein (LDL) Receptor-Related Protein

Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC)

Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase

The Putative Tumor Suppressor LRP1B, a Novel Member of the Low Density Lipoprotein (LDL) Receptor Family, Exhibits Both Overlapping and Distinct Properties with the LDL Receptor-related Protein

The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes

Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway

Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors

Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC)

Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

Association of pancreatic adenocarcinoma location (head/body/tail) with DDR mutation status and response to platinum-based therapy

Real-world clinical outcomes and molecular features of lung-specific and liver-specific metastases in pancreatic ductal adenocarcinoma (PDAC)

Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies

Real-world outcomes in pancreatic adenocarcinoma (PDAC) and persona types with implications for standard of care (SOC) therapy (Tx)

Improved overall survival (OS) for advanced pancreatic cancer (PDAC) patients (pts) enrolled in the Know Your Tumor (KYT) program whose tumors harbored highly actionable molecular alterations and who received molecularly-matched therapies (tx)

Suchergebnisse filtern